Logo image
The Emergency nurse Protocols Initiating Care—Sydney Triage to Admission Risk Tool (EPIC-START) trial: protocol for a stepped wedge implementation trial
Journal article   Open access   Peer reviewed

The Emergency nurse Protocols Initiating Care—Sydney Triage to Admission Risk Tool (EPIC-START) trial: protocol for a stepped wedge implementation trial

Kate Curtis, Michael M Dinh, Amith Shetty, Sarah Kourouche, Margaret Fry, Julie Considine, Ling Li, Thomas Lung, Timothy Shaw, Mary K. Lam, …
Implementation science communications, Vol.4, 70
20/06/2023
pdf
The Emergency nurse Protocols Initiating Care3.19 MBDownloadView
Published (Version of record)CC BY V4.0 Open Access
url
The Emergency nurse Protocols Initiating CareView
Published (Version of record)CC BY V4.0 Open

Related links

Metrics

92 File views/ downloads
67 Record Views

Abstract

Introduction Emergency department (ED) overcrowding is a global problem and a threat to the quality and safety of emergency care. Providing timely and safe emergency care therein is challenging. To address this in New South Wales (NSW), Australia, the Emergency nurse Protocol Initiating Care—Sydney Triage to Admission Risk Tool (EPIC-START) was developed. EPIC-START is a model of care incorporating EPIC protocols, the START patient admission prediction tool, and a clinical deterioration tool to support ED flow, timely care, and patient safety. The aim of this study is to evaluate the impact of EPIC-START implementation across 30 EDs on patient, implementation, and health service outcomes. Methods and analysis This study protocol adopts an effectiveness-implementation hybrid design (Med Care 50: 217-226, 2012) and uses a stepped–wedge cluster randomised control trial of EPIC-START, including uptake and sustainability, within 30 EDs across four NSW local health districts spanning rural, regional, and metropolitan settings. Each cluster will be randomised independently of the research team to 1 of 4 dates until all EDs have been exposed to the intervention. Quantitative and qualitative evaluations will be conducted on data from medical records and routinely collected data, and patient, nursing, and medical staff pre- and post-surveys. Ethics and dissemination Ethical approval for the research was received from the Sydney Local Health District Research Ethics Committee (Reference Number 2022/ETH01940) on 14 December 2022. Trial registration Australian and New Zealand Clinical trial, ACTRN12622001480774p. Registered on 27 October 2022.

Details

Logo image